Metabolic Impact of Intermittent Fasting in Patients With Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis of Interventional Studies
Borgundvaag E, Mak J, Kramer CK
The Journal of clinical endocrinology and metabolism · 64 citas
Cómo se estudió
- Diseño
- Metaanálisis (indexado por PubMed)
- Estudiado en
- Personas
- Resultado principal
- Marcadores de salud y funcionamiento
Quién lo pagó
- Financiación
- Financiación independiente
- Universidad u hospital
- Intramural Funds
Según 1 financiador declarado.
Publicación
- Publicado
- 2020-12-15 · J Clin Endocrinol Metab · vol. 106 · número 3 · págs. 902–911
- Editorial
- Oxford University Press
- Citado
- 101 citas · más que el 86% de estudios similares · 1.8× el promedio de su campo
- Referencias
- 46 trabajos
- Acceso
- Lectura gratuita
- Áreas de investigación
- Dietary Effects on Health · Diet and metabolism studies · Genetics, Aging, and Longevity in Model Organisms
- Palabras clave
- Medicine, Weight loss, Glycated hemoglobin, Meta-analysis, Body mass index, Internal medicine, Obesity, Type 2 diabetes, Type 2 Diabetes Mellitus, Randomized controlled trial, Diabetes mellitus, Population, Endocrinology
- MeSH
- humans, diabetes mellitus, type 2, obesity, weight loss, blood glucose, hypoglycemic agents, fasting, history, 20th century, history, 21st century, adult, female, male, randomized controlled trials as topic
3 autores
- Emily Borgundvaag🇨🇦Mount Sinai Hospital
- Jessica Mak🇨🇦Mount Sinai Hospital; University of Toronto
- Caroline Kaercher Kramer🇨🇦 · autor de correspondenciaMount Sinai Hospital; University of Toronto; Lunenfeld-Tanenbaum Research Institute
Resumen
El texto original del estudio, en el idioma en que se publicó.
Context
Intermittent fasting (IF) has been proposed as a weight-loss strategy with additional cardiometabolic benefits in individuals with obesity. Despite its growing popularity, the effect of IF in patients with type 2 diabetes (T2DM) remains unclear.
Objective
We conducted a systematic review and meta-analysis to evaluate the metabolic impact of IF compared to standard diet in patients with T2DM.
Methods
Embase, PubMed, and clinicaltrials.gov between 1950 and August 12, 2020 were searched for randomized, diet-controlled studies evaluating any IF intervention in adults with T2DM. We examined the impact of IF on weight loss and glucose-lowering by calculating pooled estimates of the absolute differences in body weight and glycated hemoglobin A1c (HbA1c) compared to a control group using a random-effects model.
Results
Seven studies (n = 338 participants; mean body mass index [BMI] 35.65, mean baseline HbA1c 8.8%) met our inclusion criteria. IF induced a greater decrease in body weight by -1.89 kg (95% CI, -2.91 to -0.86 kg) compared to a regular diet, with no significant between-study heterogeneity (I2 21.0%, P = .28). The additional weight loss induced by IF was greater in studies with a heavier population (BMI > 36) (-3.43 kg [95% CI, -5.72 to -1.15 kg]) and in studies of shorter duration (≤ 4 months) (-3.73 kg [95% CI, -7.11 to -0.36 kg]). IF was not associated with further reduction in HbA1c compared to a standard diet (HbA1c -0.11% [95% CI, -0.38% to 0.17%]).
Conclusion
Current evidence suggests that IF is associated with greater weight loss in patients with T2DM compared with a standard diet, with a similar impact on glycemic control.
Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial.
Confianza de la comunidad
Cargando…
¿Cuánto confías en los hallazgos de este estudio?
Comentarios
¿Algo está mal aquí?
Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.
Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.